No Data
Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Replimune Management to Meet With Jefferies
Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Replimune Group (REPL)
Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19
Replimune Group Analyst Ratings
Express News | Replimune Shares Extend Gains; Last up 8%